Sanofi announced that it has reached a settlement agreement with Eli Lilly and Company, which addresses patents on Sanofi's Lantus...
Eli Lilly and Company announced a delay in the submission of basal insulin peglispro (BIL) (LY 2605541) to regulatory agencies...